New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Saturday, Nov 21, 2026
Export SCTX’s income statement to Excel — free account
Scribe Therapeutics Inc.
SCTXScribe Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $51.2 million.
12.07
1.15
−8.70%
After hours trading: 12.00, down 0.58%, last trade Fri 7:39pm Eastern.
Follow SCTX
Alert me
What it owns vs. what it owes Q3 FY2026, Sep 30, 2026
Shareholders’ equity is 66.6% of the balance sheet. What is a balance sheet?
Owns
$9.0MLong-term assets
$4.7MOther short-term assets
$174.2MCash & short-term investments
Funded by
$125.2MShareholders’ equity
$62.8MOther liabilities
Debt is 0.00% of the total; shareholders’ equity 66.6%.
| Older periods | Sep '25 | Dec '25 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
+1 more quarter Free account |
— | 57.96 | 43.01 | 174.23 |
Receivables |
— | 7.09 | 1.11 | 0.87 | |
Total current assets |
— | 66.93 | 45.11 | 178.89 | |
Property, Plant, Equpment (Net) |
— | 7.01 | 5.76 | 5.15 | |
Goodwill and Intangible Assets (Total) |
0.00 | — | — | — | |
Long-term assets (Other) |
— | 1.21 | 4.29 | 1.26 | |
Total non-current assets |
— | 11.29 | 12.82 | 9.04 | |
Total Assets |
— | 78.22 | 57.93 | 187.93 | |
Notes Payable |
— | 35.34 | 37.80 | — | |
Accounts Payable |
— | 4.57 | 2.77 | 2.77 | |
Accrued Expenses |
— | 6.41 | 7.18 | 8.33 | |
Current Part of Capital Lease |
0.00 | — | — | — | |
Current Part of Taxes to Pay |
0.00 | — | — | — | |
Current Revenue (Deferred) |
— | 21.09 | 27.48 | 25.42 | |
Total current liabilities |
— | 69.06 | 78.70 | 37.93 | |
Non-current Revenue (Deferred) |
0.00 | 19.94 | 11.70 | 12.95 | |
Minority Interests |
0.00 | — | — | — | |
Non-current Liabilities (Other) |
— | 7.49 | 7.92 | 8.15 | |
Total non-current liabilities |
— | 32.23 | 23.72 | 24.83 | |
Total liabilities |
— | 101.28 | 102.42 | 62.76 | |
Additional Paid In Capital |
0.00 | 14.24 | 16.67 | 316.53 | |
Preferred Stock (Total) |
0.00 | 120.36 | 120.36 | — | |
Common Stock (Net) |
0.00 | 0.01 | 0.01 | 0.04 | |
Retained Earnings |
— | (157.71) | (181.53) | (191.39) | |
Treasury Stock |
0.00 | — | — | — | |
Shareholders Equity (Other) |
0.00 | — | — | — | |
Common Equity (Total) |
— | (143.42) | (164.85) | 125.17 | |
Shareholders Equity (Total) |
— | (23.06) | (44.49) | 125.17 | |
Shareholders Equity and Liabilities (Total) |
— | 78.22 | 57.93 | 187.93 | |
Shares (Common) |
— | 2.45 | 2.49 | 18.94 | |
Shares (Preferred) |
— | 4.92 | 4.92 | — | |
Shareholders Equity (Tangible) |
— | (23.06) | (44.49) | 125.17 | |
Net Debt |
— | (57.96) | (43.01) | (174.23) |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026